NCT07180914View on ClinicalTrials.gov

A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for Hormone Receptor-positive(HR+) Premenopausal Breast Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

October 10, 2025

Primary Completion Date

July 31, 2029

Study Completion Date

December 31, 2029

Conditions

Breast Cancer Females

All Listed Sponsors

collaborator

Beijing Health Promotion Association

UNKNOWN

lead

Zhejiang Cancer Hospital

OTHER